A Post Marketing Surveillance Study of INVOSSA K Inj.
Post Marketing Surveillance on Safety and Effectiveness Evaluation of INVOSSA K Inj.
Sponsor: Kolon Life Science
A observational or N/A phase clinical study on Osteoarthritis, this trial is ongoing. The trial is conducted by Kolon Life Science and has accumulated 9 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Aug 2023 — Jul 2024 [monthly]
Unknown Status
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Aug 2023 [monthly]
Active Not Recruiting
▶ Show 4 earlier versions
-
Jun 2019 — Jan 2021 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Jun 2019 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Feb 2018 — Apr 2018 [monthly]
Recruiting NA
First recorded
Jul 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Kolon Life Science
For direct contact, visit the study record on ClinicalTrials.gov .